TCF1GFP Pmel-1 ACT significantly inhibited B16F10 tumor growth, while tumor growth in the Irf4–/–TCF1GFP Pmel-1 ACT group was comparable to the No ACT group (Fig. 5B). The gene discussed is IRF4; the disease is neoplasm.